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Objectives: We investigated whether bone morphogenetic protein 2, released slowly
from a gelatin sponge, could induce cartilage regeneration in a canine model of
tracheomalacia and evaluated the long-term results.
Methods: A 1  5-cm gap was made in the anterior cervical trachea by removing
5-cm long strips of 10 sequential cartilagines. In the control group (n  5), the gaps
were left untreated. In the gelatin sponge group (n  5), a gelatin sponge soaked in
a buffer solution was implanted in each defect. In the bone morphogenetic protein
group (n  5), a gelatin sponge soaked in a buffer solution containing 12 g bone
morphogenetic protein 2 was implanted in each defect.
Results: Tracheomalacia was observed in the control and gelatin sponge groups but
not in the bone morphogenetic protein group. No regenerated cartilage was detected
in the control or gelatin sponge groups, even 6 months after surgery. In contrast,
regenerated cartilage, which had developed from the host perichondrium, was
observed around the stumps of the resected cartilagines in the bone morphogenetic
protein group. This regenerated cartilage maintained the integrity of the internal
lumen for longer than 6 months. A compressive fracture test revealed that the
tracheal cartilage in the bone morphogenetic protein group was significantly more
stable than that in the gelatin sponge and control groups (P  .0015 and P  .0001,
respectively).
Conclusions: In this canine model of tracheomalacia, cartilage regeneration was
induced around the stumps of tracheal cartilagines by bone morphogenetic protein
2 released slowly from a gelatin sponge. This regenerated cartilage was not reab-
sorbed for longer than 6 months and was strong enough to maintain the integrity of
the internal lumen of the trachea.
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Despite the fact that tracheomalacia is notrare, there is as yet no generally acceptedtreatment for this condition.1 Althoughwe have developed a method for trachealtransplantation,2-5 it is not suitable fortreating tracheomalacia because too long
a segment of trachea is usually affected by the disease. For
some years we have been involved in the development of
artificial organs, in which regeneration of the host tissue is
induced by means of bioabsorbable materials, and have
succeeded in regenerating sections of the canine esopha-
gus.6-8 We are now focusing on inducing the regeneration of
host tracheal tissue to form an artificial trachea. The normal
trachea is composed of a mucosal layer, a submucosal layer,
tracheal glands, a smooth muscle layer, and the tracheal
cartilagines, with the most important structures being the
mucosa, which inhibits the invasion of exogenous organ-
isms, and the cartilage, which maintains the integrity of the
tracheal lumen. The first step in our attempt to produce an
artificial trachea was to try to induce the regeneration of
tracheal cartilage with bone morphogenetic protein 2 (BMP-
2), released slowly from a gelatin sponge. BMP-2 has been
identified as a cartilage- and bone-inducing molecule and
has been shown to enhance chondrogenesis and osteogene-
sis in various animal models. It can now be cloned and
synthesized by recombinant techniques. Our initial studies
were based on the hypothesis that BMP-2 would induce the
regeneration of cartilage and bone in an experimentally
produced gap in the tracheal cartilage, with the expected
outcome that our method would be useful in the treatment of
tracheomalacia. In a previous article,9 we reported the short-
term results of implanting a gelatin sponge containing a
BMP-2 solution into a tracheal cartilage gap, which dem-
onstrated that such an implant could induce cartilage regen-
eration. In this article, we report the long-term results of the
same study, covering an observation period of longer than 6
months.
Materials and Methods
This experiment was carried out in accordance with the “Guide for
the Care and Use of Laboratory Animals” prepared by the Institute
of Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996 (http://
nap.edu/catalog/5140.html).
Preparation of BMP-2–Containing Gelatin Sponge
The manufacture of the BMP-2–containing gelatin sponge was
described in our previous article.9 Briefly, an aqueous solution of
gelatin containing glutaraldehyde was cast in a mold and stored at
4°C for 12 hours. The material was then immersed in glycine
solution at 37°C to block any residual glutaraldehyde, washed with
distilled water, and finally freeze-dried and sterilized. The result-
ing gelatin sponge was trimmed into pieces measuring approxi-
mately 1.0 5.0 cm, and each was soaked in a solution containing
12 g BMP-2. This solution was prepared by dissolving BMP-2 in
a buffer (5-mmol/L glutamic acid, 2.5% glycine, 0.5% sucrose,
and 0.01% polysorbate 80) at a concentration of 1 g/1 L, then
adding distilled water to a final volume of 5 mL.
Previous studies have shown that a BMP-2 dose of 10 g is
enough to induce ectopic bone formation in mice.10 In our labo-
ratory, BMP-2 solution is routinely divided into microtubes con-
taining a 12-g dose and stored in a refrigerator. We therefore
selected this dose partly for convenience and partly to represent a
low initial dose.
Surgical Procedures
Fifteen adult mongrel dogs weighting 10 to 14 kg were used in this
study. A 1  5-cm gap in the anterior tracheal cartilage was
created by removing 5-cm long strips of 10 sequential cartilagines
from the middle of the cervical region. The tracheal mucosa was
carefully preserved throughout the procedure (Figure 1). In the 5
dogs acting as a control group, the gap was left unfilled. A gelatin
sponge soaked in the buffer solution alone was implanted to
replace the resected portion of the tracheal cartilage in 5 further
dogs (gelatin sponge group). A gelatin sponge soaked in solution
containing 12 g BMP-2 was implanted to replace the resected
portion of the tracheal cartilage in the 5 remaining dogs (BMP
group; Figure 2).
Follow-up Studies
Routine bronchoscopic examinations were done at 1, 3, 6, 12, and
15 months after the operation. The animals were killed at 1, 3, or
6 months after surgery. The trachea was immediately removed and
fixed in 10% formalin, and the cervical trachea was examined
histopathologically. In addition, the anterior cartilaginous portion
of each trachea was mounted on a Creepmeter (RE 330055;
Yamaden Co Ltd, Tokyo, Japan), and a compressive fracture test
was performed. The stress required to produce breaks in the
cartilage was measured and used as an estimate of the stability of
the tracheal cartilage.11,12 Six preparations were made from 1
animal in each group at 3 months after the operation.
Figure 1. Surgical procedure for control group: 1  5-cm gap in
tracheal cartilage was created by removing 5-cm long strips of 10
sequential cartilage rings, taking care not to damage mucosa.
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All the dogs survived without any major health problems
until they were killed as planned (Table 1). However, the
dogs in the control and gelatin sponge groups demonstrated
stridor during barking or coughing. None of the dogs in the
BMP group had stridor.
Bronchoscopic Findings
Throughout the observation period, routine bronchoscopic
examinations revealed collapse of the tracheal lumen during
coughing in both the control group (Figure 3) and the
gelatin sponge group (Figure 4). Although slight stenosis of
the tracheal lumen was observed in the BMP group at rest,
the tracheal wall was firmly fixed in this group and did not
collapse during coughing (Figure 5). The findings for all the
groups remained essentially unchanged throughout the ob-
servation period, which lasted longer than 6 months.
Microscopic Findings
Control group. Microscopic observations revealed no
cartilage regeneration, even at 6 months after the operation,
although the ends of the stumps of the cartilagines were
covered with perichondrium. The submucosal layer over the
cartilage gap was thicker than normal (Figure 6).
Gelatin sponge group. The findings were similar to
those in the control group. The gelatin sponge had disap-
TABLE 1. Clinical findings
Dog No. Survival (mo.) Status Malacia
Control group
1 1 Planned death 
2 3 Planned death 
3 6 Planned death 
4 14 Planned death 
5 6 Alive 
Gelatin sponge group
1 1 Planned death 
2 3 Planned death 
3 6 Planned death 
4 6 Alive 
5 6 Alive 
BMP group
1 1 Planned death 
2 3 Planned death 
3 6 Planned death 
4 12 Planned death 
5 15 Planned death 
Figure 3. Bronchoscopic findings in control group 6 months after
surgery. Tracheal lumen collapsed during coughing. a, At rest; b,
during coughing.
Figure 4. Bronchoscopic findings in gelatin sponge group 6
months after surgery. Tracheal lumen collapsed during coughing.
a, At rest; b, during coughing.
Figure 5. Bronchoscopic findings in BMP group 6 months after
surgery. Slight tracheal stenosis was observed, but there was no
collapse, even during coughing. a, At rest; b, during coughing.
Figure 2. Surgical procedures for gelatin sponge and BMP
groups: gap in tracheal cartilage was created as shown in Figure
1. Gelatin sponge soaked in buffer solution alone or solution
containing 12 g BMP-2 was then implanted into gap.
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peared 1 month after the operation; thus the gelatin sponge
itself did not induce regeneration of cartilage (Figure 7).
BMP group. Newly formed cartilage arising from peri-
chondrium surrounding the stumps of the cartilagines was
observed 1 month after implantation of the sponge. The
regenerated cartilage was directed mainly toward the lumi-
nal or contraluminal side, rather than toward the center of
the gap. The distance between the cartilage stumps was
shortened. The gap was filled with amorphous connective
tissue that invaded the cartilage gap. The regenerated car-
tilage was similar to fibrous cartilage but differed from the
hyaline cartilage found in the host trachea. It consisted of
immature chondrocytes with a poorly developed, nonhomo-
geneous extracellular matrix. At 6 months after implanta-
tion, regenerated cartilage was detected arising from the
perichondrium on both sides of the gap, and the gap was
filled with fibrous tissue. Again, the direction of regenera-
tion was mainly toward the contraluminal side of the tra-
chea, rather than toward the center of the gap (Figure 8).
The regenerated cartilage was covered with perichondrium.
Compressive Fracture Test of Tracheal Cartilage
The stress levels required to produce breaks in the anterior
tracheal cartilage (Table 2) were 3.52  1.03  106 N/m2
for the normal trachea (n  6 specimens), 4.92  1.32 
106 N/m2 for the BMP group (n  6 specimens), 1.68 
1.26  106 N/m2 for the gelatin sponge group (n  6
specimens), and 0.68  0.43  106 N/m2 for the control
group (n  6 specimens). The tracheal cartilage was sig-
nificantly more stable in the BMP group than in the gelatin
sponge group (P  .0015) and the control group (P 
.0001). In addition, it was significantly more stable than
normal trachea in the BMP group (P  .013), and it was
significantly more fragile than normal trachea in the control
group (P  .001) and gelatin sponge group (P  .002).
Figure 7. Microscopic finding in gelatin sponge group 6 months
after implantation. No cartilage regeneration is detectable
around cartilageal stump (arrow). (Original magnification 150).
Figure 6. Microscopic findings in control group 6 months after
surgery. No cartilage regeneration is detectable around cartila-
geal stump (arrow). (Original magnification 150).
Figure 8. Microscopic finding for BMP group 6 months after
implantation. Regenerated cartilage (thin arrow) arising from
perichondrium can be seen around stump (thick arrow) of re-
sected cartilagines. (Original magnification 150).
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Persistent coughing and stridor during barking were ob-
served in the control and gelatin sponge groups. Bronchos-
copy revealed that these dogs had tracheomalacia in the area
around the partial resection of the tracheal cartilage. These
findings remained essentially unchanged throughout an ob-
servation period longer than 6 months. One of the potential
causes of tracheomalacia, especially saber sheath–type tra-
cheomalacia, is laceration and weakness of the tracheal
cartilage.13,14 Our experimental procedures were therefore
appropriate for constructing a model of this type of tracheo-
malacia, as typified by the control group. Follow-up micro-
scopic observations in this group revealed no cartilage or
bone regeneration, and the gap did not shrink. Similarly, no
regeneration of cartilage was observed in the gelatin sponge
group, indicating that the gelatin sponge itself does not
promote regeneration.
In the BMP group, regenerated cartilage was observed at
the ends of the stumps of the host cartilage, with the
direction of regeneration toward the luminal or contra-
luminal side rather than toward the center of the cartilage
gap. However, the regeneration process seemed to stop 3
months after implantation, and regeneration was limited to
the cartilage stumps even at 6 months. Nevertheless, even
this small amount of regenerated cartilage was able to
maintain the integrity of the internal lumen of the trachea.
The remaining gap was filled not with cartilage, but with
amorphous connective tissue that may have represented a
postinflammatory reaction.10 Because our microscopic ob-
servations revealed no such tissue in the gelatin sponge and
control groups, this phenomenon may have resulted from
the wound healing process or a foreign-body reaction
caused by the gelatin10,15 or BMP-2, which may have en-
hanced any postinflammatory reaction. Gelatin is a biode-
gradable material that induces fibroblast migration during
its absorption.6-8,16 These migrated fibroblasts become myo-
fibroblasts, which are involved in wound contraction during
healing.6-8 Contrary to our expectations, BMP-2 did not
induce the differentiation of such fibroblasts into osteocytes
or chondrocytes. Previous studies have shown that a BMP-2
dose of 10 g or less is enough to induce ectopic bone
formation in mice,10 but not in rats17 or dogs.18 In this
study, however, cartilage regeneration from the perichon-
drium was observed around the cartilage stumps in the BMP
group but not in the control or gelatin sponge groups,
despite the low BMP-2 dose used. These results indicate
that even a low dose of BMP-2 can promote cartilage
regeneration from perichondrium in dogs, and that slow
release of BMP-2 from a gelatin sponge can successfully
induce the regeneration of cartilage in a canine tracheoma-
lacia model. Although the regeneration of cartilage was
limited, and slight narrowing of the trachea was observed at
rest, the internal lumen of the trachea was maintained even
during coughing. Furthermore, the regenerated cartilage had
not been reabsorbed 6 months after the operation. In addi-
tion, a compressive fracture test revealed that the cartilage
in the BMP group was significantly more stable than that in
the control and gelatin sponge groups, or in normal trachea.
Importantly, the implantation procedure is relatively easy to
perform and can be carried out in the segmental bronchial
area. In the clinical setting of tracheomalacia, the immature
cartilage is covered with connective tissue. The direct con-
tact of cartilage with BMP-2 may be essential to form new
cartilage.
Conclusion
Long-term observations demonstrated that our control
group fits the requirements for a tracheomalacia model.
Slow release of BMP-2 from a gelatin sponge induced the
regeneration of cartilage in this model. Furthermore, the
newly formed cartilage was capable of maintaining the
integrity of the internal lumen of the trachea through a long
period without being resorbed.
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